drugset / Trial / NCT00393744
Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in Children
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to demonstrate the non-inferiority, at the assessment visit (V3 (D10/D14)), in terms of bacteriological efficacy of pristinamycin (PRI) administered for 4 days versus amoxicillin (AMX) administered for 6 days in the treatment of tonsillitis caused by GAS, in subjects aged between 6 and 25 in the per protocol (PP) group.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 50 mg/kg | Oral |
| Comparator | Amoxicillin | Other / unclassified | 1 g | Oral |
| Subject | PRISTINAMYCIN | Unknown | 50 mg/kg | Oral |
| Subject | PRISTINAMYCIN | Unknown | 1 g | Oral |